During transcription DNA produces::

A. All of these choices are correct: When prescribing antimicrobial medications, physicians must consider multiple patient-specific factors that influence drug safety, metabolism, and therapeutic effectiveness. Variables such as liver function, alcohol use, pregnancy status, and patient age can significantly alter how a drug is metabolized, distributed, and tolerated. Each listed factor can influence antimicrobial selection or dosage.

B. Liver function: Many antimicrobial agents are metabolized in the liver through hepatic enzyme systems such as cytochrome P450. Impaired liver function can reduce drug metabolism, leading to accumulation and potential toxicity. Physicians often adjust dosages or select alternative medications in patients with hepatic disease to prevent adverse drug reactions.

C. Alcohol use: Alcohol consumption can interact with several antimicrobial medications and alter liver metabolism. For example, drugs such as metronidazole can cause a disulfiram-like reaction when combined with alcohol. Chronic alcohol use may also impair immune function and liver metabolism, affecting drug choice and dosing.

D. Pregnancy: Pregnancy influences antimicrobial prescribing because some drugs can cross the placenta and harm the developing fetus. Certain antimicrobials, such as tetracyclines and fluoroquinolones, are avoided due to risks like fetal bone growth inhibition or cartilage damage. Physicians must carefully select medications that are considered safe during pregnancy.

E. Patient age: Age affects pharmacokinetics and pharmacodynamics, including drug absorption, distribution, metabolism, and excretion. Infants and older adults may have reduced renal or hepatic function, increasing the risk of drug accumulation or toxicity. Physicians frequently adjust antimicrobial dosing based on age-related physiological changes.

When a control agent targets metabolic processes, actively growing and metabolizing cells are more susceptible than older or dormant cells. Younger microbial cells have higher rates of enzyme activity, protein synthesis, and energy production, which are the pathways most affected by metabolic inhibitors. In contrast, older or stationary-phase cells have slowed metabolism and often possess stress adaptations that make them less vulnerable to these agents. Therefore, treatments that disrupt metabolism such as certain antibiotics or chemical disinfectants tend to kill actively dividing cells more rapidly, while non-dividing or metabolically inactive cells survive longer.